IRF2BPL‐Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) Is Characterized by Pathology Consistent with DRPLA

• Published in: Movement disorders 2024-11, Vol.39 (11), p.2102-2109
• Main Authors: Venkateswaran, Sunita, Michaud, Jean, Ito, Yoko, Geraghty, Michael, Lewis, Evan C., Ellezam, Benjamin, Boycott, Kym M., Dyment, David A., Kernohan, Kristin D.
• Format: Article
• Language: English
• Subjects: Ataxia; Atrophy; Brain - pathology; Carrier Proteins; Child; Children; Differential diagnosis; DRPLA; Dystonia; Female; Humans; Interferon regulatory factor; Interferon regulatory factor 2; IRF2BPL; Male; Movement Disorders - genetics; Movement Disorders - pathology; mRNA; NEDAMSS; Neurodegeneration; Neurodegenerative diseases; Neurodevelopmental disorders; Neurodevelopmental Disorders - diagnosis; Neurodevelopmental Disorders - genetics; Nuclear Proteins; Polyglutamine diseases; polyglutamine repeats; Seizures; Seizures - genetics; Spasticity; spastic‐ataxia; Speech; Trinucleotide repeat diseases; Trinucleotide repeats; Whole genome sequencing
• ISSN: 0885-3185; 1531-8257; 1531-8257
• DOI: 10.1002/mds.29938

Background Childhood neurodegenerative diseases often pose a challenge to clinicians to diagnose because of the degree of genetic heterogeneity and variable presentations. Here, we present a child with progressive neurodegeneration consisting of spasticity, dystonia, and ataxia in which postmortem pathological analysis led to the diagnosis of interferon regulatory factor 2 binding protein like (IRF2BPL)‐related disorder. Methods Detailed postmortem gross and histological examination was conducted, and findings consistent with dentatorubral‐pallidoluysian atrophy (DRPLA) and included polyglutamine (polyQ) inclusions. Follow up testing for the CAG repeat expansion at ATN1 was non‐diagnostic. Results Subsequent exome sequencing reanalysis of the research exome identified a pathogenic de novo IRF2BPL variant. The IRF2BPL c.562C>T, p.(Arg188Ter) variant, distal to the polyQ repeat tract, results in variable mRNA levels depending on the cell type examined with decreased mRNA in the brain, as well as destabilization of the protein product and corresponding downstream molecular abnormalities in patient derived cells. Conclusion We provide the first detailed pathological description for IRF2BPL‐related disorder, termed NEDAMSS (neurodevelopmental disorder with regression, abnormal movements, loss of speech and seizures; Mendelian Inheritance in Man, 618088) and evidence for the inclusion of this condition in the differential diagnosis of spastic‐ataxic neurodegenerative conditions, reminiscent of DRPLA. Although the individuals with NEDAMSS do not carry an expansion, the polyQ repeat tract may play a role in the pathological inclusions that would represent a novel disease mechanism for polyQ repeats. © 2024 International Parkinson and Movement Disorder Society.